Glycemic control predicts the Brain-derived neurotrophic factor levels in diabetic neuropathy patients with a diabetic duration of at least 5 years: A cross-sectional study
F1000Research · 2026
DOI: 10.12688/f1000research.172834.4 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift F1000Research, 2026. Verfasst von Maria Suryani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nursing, Sekolah Tinggi Ilmu Kesehatan Elisabeth Semarang, Semarang, Central Java, Indonesia. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Diabetic Neuropathies, Diabetes Mellitus, Type 2, Glycemic Control. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia.
Abstract (Originalsprache)
Background
Diabetic neuropathy is one of the complications of diabetes that occurs due to poor glycemic control. Brain-derived neurotrophic factor (BDNF) levels can increase when patients are first diagnosed with type 2 diabetes mellitus and can change in response to glycemic control conditions throughout the course of the disease. However, the correlation between glycemic control and BDNF remains unclear. The objective of this study was to investigate whether glycemic control can predict the BDNF levels in patients with diabetic neuropathy, based on diabetic duration.
Methods
A cross-sectional study was conducted on 8 patients with diabetic neuropathy who were treated at a clinic in Central Java. We use glycated hemoglobin (HbA1c) levels as a parameter of glycemic control, which were measured according to the National Glycohemoglobin Standardization Program. BDNF serum levels were evaluated using the Enzyme-Linked Immunosorbent Assay (ELISA) method in the laboratory. Analysis was performed using ANCOVA tests.
Results
Together, HbA1c levels, diabetic duration, and interactions between diabetic duration and HbA1c explained 9.9% of variability in BDNF levels (p=0.046). However, HbA1c levels explained 8.1% of the variability in BDNF levels (p = 0.011), with only minor contributions from diabetic duration and interaction them.
Conclusions
The HbA1c levels significantly explained the variability in BDNF levels in patients with diabetic neuropathy regardless of diabetic duration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nursing, Sekolah Tinggi Ilmu Kesehatan Elisabeth Semarang, Semarang, Central Java, Indonesia.
ORCID-Profile: Maria Suryani, Medina Sianturi
Förderung
- Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia
Zitieren
APA
Suryani, M., Ermi Tri Sulistiyowati, M. A., & Sianturi, M. (2026). Glycemic control predicts the Brain-derived neurotrophic factor levels in diabetic neuropathy patients with a diabetic duration of at least 5 years: A cross-sectional study. F1000Research. https://doi.org/10.12688/f1000research.172834.4
Vancouver
Suryani M, Ermi Tri Sulistiyowati MA, Sianturi M. Glycemic control predicts the Brain-derived neurotrophic factor levels in diabetic neuropathy patients with a diabetic duration of at least 5 years: A cross-sectional study. F1000Research. 2026. doi:10.12688/f1000research.172834.4
BibTeX
@article{Suryani2026,
author = {Suryani, Maria and Ermi Tri Sulistiyowati, Maria Agustina and Sianturi, Medina},
title = {Glycemic control predicts the Brain-derived neurotrophic factor levels in diabetic neuropathy patients with a diabetic duration of at least 5 years: A cross-sectional study},
journal = {F1000Research},
year = {2026},
doi = {10.12688/f1000research.172834.4}
}
EUVIMED